Alterna Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-21,867
Closed -$74K 111
2020
Q1
$74K Sell
21,867
-4,095
-16% -$17.7K 0.11% 72
2019
Q4
$142K Hold
25,962
0.16% 109
2019
Q3
$149K Sell
25,962
-3,735
-13% -$25.4K 0.18% 115
2019
Q2
$227K Sell
29,697
-3,277
-10% -$17.6K 0.27% 75
2019
Q1
$173K Sell
32,974
-47,190
-59% -$327K 0.15% 96
2018
Q4
$524K Buy
+80,164
New +$898K 0.09% 168

Other funds holding PGEN

Alterna Wealth Management's PGEN Position: Q2 2020 in Review

Alterna Wealth Management sold out of Precigen (PGEN) in Q2 2020, closing a stake of 21,867 shares — an estimated $74K sold.

Alterna Wealth Management first reported a position in PGEN in Q4 2018 and held it in 6 quarters. The position peaked at $524K in Q4 2018. 154 funds tracked by Wall St. Rank hold PGEN as of Q2 2020.

  • Alterna Wealth Management reported no remaining Precigen position as of Q2 2020 after selling out during the quarter.
  • Alterna Wealth Management sold 21,867 Precigen shares in Q2 2020, an estimated $74K.
  • Alterna Wealth Management first reported a position in Precigen in Q4 2018 and held it in 6 quarters.
  • Alterna Wealth Management's Precigen position peaked at $524K in Q4 2018.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q2 2020.

Based on Alterna Wealth Management's 13F filing for Q2 2020, filed 27 Jul 2020.